Laboratoires Thea
Clinical trials sponsored by Laboratoires Thea, explained in plain language.
-
New eye drop trial aims to tame severe childhood eye allergy
Disease control Not yet recruitingThis study aims to see if a new investigational eye drop called T1695 is as effective and safe as an existing standard treatment (ciclosporin) for children and teenagers with moderate to severe vernal keratoconjunctivitis (VKC), a severe form of seasonal eye allergy. It will invo…
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New eye drop study targets stubborn dry eye inflammation
Disease control Not yet recruitingThis study is observing how well a prescription eye drop containing cyclosporine works for people with moderate to severe dry eye disease. It focuses on patients whose dry eye symptoms and related eye surface inflammation haven't improved enough with regular artificial tear drops…
Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Feb 27, 2026 15:18 UTC
-
New cream aims to soothe recovery after eyelid surgery
Symptom relief Not yet recruitingThis study is testing how satisfied patients are with a new preservative-free eyelid cream used after eyelid surgery. Thirty adults who have had eyelid surgery will use the cream twice daily for three months. Researchers will measure their satisfaction with the cream's effect on …
Sponsor: Laboratoires Thea • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC